Guru Ownership Trend
Guru Analysis for Atea Pharmaceuticals, Inc. (AVIR)
Atea Pharmaceuticals, Inc. (AVIR), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $7.6 M.
Top institutional holders include Renaissance Technologies (RenTech) and Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $130,570.06 net inflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 437.2%. Conversely, Renaissance Technologies (RenTech) reduced exposure by 3.0%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Atea Pharmaceuticals, Inc. (AVIR)
Major holders include Renaissance Technologies (RenTech) ($5.26 M), Cliff Asness ($1.15 M). According to the latest reported data, 2 tracked investment managers collectively hold approximately 1.38 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $130,570.06, with 1 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited AVIR. The total reported sell value was $806,875.
Yes, 0 managers opened new positions in AVIR, and 1 increased their existing holdings. The total reported buy value was $937,445.06.